Introduction
The worldwide dissemination of fluoroquinolone (FQ) resistant Escherichia coli isolates is a significant challenge to antibiotic treatment and infection control policies (1) . In E. coli, a gram-negative bacterium, resistance to FQs primarily occurs from mutations in the quinolone resistance determining region (QRDR) of the genes encoding the drug target enzymes (DNA gyrase and topoisomerase IV) (2) . In addition, plasmid-mediated quinolone resistance (PMQR) genes, such as the target protection PMQR gene qnr, the enzymatic modification gene aac (6' )Ib-cr, and efflux pump genes qepA and oqxB, have also been shown to increase the MICs of FQs (3) (4) (5) . Overexpression of the multidrug efflux pump AcrABTolC has been shown to directly contribute to multidrug resistance (MDR) in E. coli and controls the susceptibility of E. coli strains to many structurally unrelated antibiotics, including β-lactams, FQs, and aminoglycosides (6) . AcrAB is regulated primarily by the local repressor AcrR and global regulators such as MarA and its homologs SoxS and Rob in E. coli (7) .
Although FQs have been widely used in human and veterinary medicine in Turkey, most studies of FQ resistance focused on human isolates (8, 9) . Therefore, the aims of the present study were to identify QRDR (gyrA, gyrB, parC, and parE) mutations, to detect PMQR genes (qnrA, qnrB, qnrS, qepA, oqxB, and aac(6')Ib-cr), and to evaluate the expression of genes encoding MarA, AcrB, and SoxS in E. coli isolates of animal origin.
Materials and methods

Strains and susceptibility testing
Random amplified polymorphic DNA (RAPD) analysis was used to determine the genetic relatedness of 58 E. coli isolates from cattle, goats, sheep, cats, and dogs. Twenty different RAPD patterns were observed among these isolates and one representative isolate was chosen from each pattern based on resistance genotype.
Broth microdilution testing was carried out to determine the MICs of nalidixic acid (NAL), enrofloxacin (ENR), danofloxacin (DAN), ciprofloxacin (CIP), orbifloxacin (ORB), moxifloxacin (MFX), ampicillin (AMP), cefotaxime (CTX), tetracycline (TET), erythromycin (ERY), gentamicin (GEN), chloramphenicol (CHL), sulfamethoxazole (SMX), and trimethoprim (TMP) according to the guidelines of the Clinical Laboratory Standards Institute (10) . The specific breakpoints, as set in previous studies (10) (11) (12) , used in this study to determine susceptibility were as follows: CIP > 1 µg/mL, MFX > 1 µg/mL, AMP > 8 µg/mL, CTX > 2 µg/mL, GEN > 4 µg/ mL, CHL > 8 µg/mL, SMX > 4 µg/mL, TMP > 4 µg/mL, NAL > 16 µg/mL, ENR > 4 µg/mL, ORB > 8 µg/mL, and TET > 4 µg/mL. To identify differences in the degree of resistance between the isolates, the sum of MIC values was calculated by the addition of the MIC values for 14 antimicrobial agents. 2.2. PCR amplification DNA was extracted from bacterial cultures using the Genomic DNA Purification Kit (Fermentas) according to the manufacturer's instructions. QRDR and PMQR genes were amplified using specific primers as described in Table 1 and PCR products of gyrA, gyrB, parC, and parE were sequenced by Macrogen, Inc. The presence of qnrA, qnrB, qnrS, qepA, and oqxB genes was determined by PCR amplification as described previously (3, 13, 14) . The aac(6') Ib gene was amplified as described previously by Park et al. (15) ; PCR amplimers representing the aac(6')Ib gene were sequenced by Macrogen, Inc. in order to identify aac(6') Ib-cr.
Quantitative real-time-PCR (qRT-PCR)
RNA was extracted using the RNA Purification Kit (Fermentas) according to the manufacturer's instructions. Genomic DNA was removed by DNase I according to the manufacturer's instructions (Fermentas). The synthesis of cDNA used the 'RevertAid' First Strand cDNA Synthesis Kit (Fermentas). Template RNA (1 µg/mL) and oligo (dT) 18 primers in a final volume of 12 µL were incubated at 65 °C for 5 min and then the following components were added: 4 µL of 5X reaction buffer, 1 U/µL RiboLock RNase inhibitor, 1 mM dNTP mix, and 10 U/µL RevertAid M-MuLV reverse transcriptase. The 20-µL mixture was incubated at 42 °C for 60 min. An additional incubation at 70 °C for 5 min terminated the reactions. The cDNA was diluted 1:10 with nuclease-free water prior to the qRTPCRs. 16S rRNA was used as a housekeeping gene. E. coli AG100 was used as a control strain. Overexpression was defined as a 1.5-fold increase in the expression of marA, soxS, and acrB as described previously by Karczmarczyk et al. (16) . Amplification reactions were carried out in duplicate.
Accumulation of Hoechst 33342 by E. coli isolates
Efflux activity of the 20 E. coli isolates was determined by measuring accumulation of the fluorescent dye Hoechst 33342 (bisbenzimide: 2.5 µM). Measurements were taken at excitation and emission wavelengths of 350 nm and 460 nm, respectively, over 120 min using a FLUOstar OPTIMA as previously described (17).
Results
In the present study, E. coli isolated from cattle (n = 17), sheep (n = 2), and a cat (n = 1) demonstrated a high level of resistance to 14 different antimicrobial agents. The susceptibility profiles of the 20 isolates were determined and the sum of MIC values ranged from 565 to 2520 µg/ mL. The MICs of NAL, ENR, DAN, ORB, MFX, AMP, CTX, ERY, CHL, SMX, and TMP against the 20 E. coli isolates were higher than the breakpoint concentrations of these antibiotics. Fifteen of the E. coli isolates (75%) were resistant to all antibiotics tested in the study. E. coli E94 was susceptible to CHL; E. coli E95 and E. coli E247 were susceptible to CTX and GEN; E. coli E248 was susceptible to CIP, CTX, GEN, CHL, and TMP; and E. coli E308 was susceptible to CTX, TET, and CHL. The DNA sequences of gyrA, gyrB, parC, and parE were amplified, sequenced, and analyzed using the BLAST program (http://blast.ncbi.nlm.nih.gov/Blast.cgi). E. coli isolates carried a variety of alterations in gyrA (Ser -83 → Leu, Asp -87 → Asn), parC (Ser -80 → Ile), and parE (Ser -458 → Ala). The number of E. coli isolates having single, double, and triple topoisomerase mutations was 2, 10, and 5, respectively. The number of E. coli isolates with mutations in gyrA, parC, and parE was 16, 16, and 5, respectively; mutation in the gyrB gene was not observed ( Table 2 ). The number of qnrA1 -, qnrS1 -, oqxB -, and aac(6')Ib-cr-containing E. coli isolates was 1, 4, 1, and 17, respectively; qnrB and qepA were not detected in any of the E. coli isolates. PMQR genes and the number of gyrA, parC, gyrA/parC, and gyrA/parC/parE mutations in aac(6')Ib-crcontaining E. coli isolates was 1, 1, 9, and 4, respectively. QRDR mutations were not detected in qnrA1-containing E. coli E101 and qnrS1-containing E. coli E103 and E248 isolates. However, qnrS1-and oqxB-containing E. coli E247 showed mutations at codons 83 and 87 of gyrA and codon 80 of parC. In addition to amino acid substitutions in gyrA and parC, qnrS1-containing E. coli E308 showed point mutations in parE.
The relative changes in the expression of marA, acrB, and soxS are shown in Table 2 . Increased expression of acrB and soxS was detected in 2 and 9 isolates, respectively; increased expression of marA was not detected in any of the E. coli isolates. The most resistant isolate according to the sum of MIC values, E97, and E. coli E100 had mutations in the QRDR genes, and aac(6')Ib-cr plus increased acrB expression. E. coli isolates in the study were grouped as isolates with decreased efflux activity (E78, E81, E84, E85, and E95) and those with increased a efflux ctivity (E73, E75, E92, E93, E94, E96, E97, E100, E101, E102, E103, E104, E247, E248, and E308) ( Table 2 ).
Discussion
Twenty E. coli isolates with an MDR phenotype and distinct RAPD banding patterns were identified. Antimicrobial resistance profiles of 128 isolates from environmental and clinical sources were established on the basis of total MIC values of 14 different antimicrobial agents by Afifi et al. (18) ; their results showed that environmental and clinical sources were potential reservoirs for MDR. The majority of the MDR E. coli were isolated from cattle in the present study. This result indicates that cattle may be an important vector for the dissemination of MDR E. coli among animals as well as from animals to humans.
In the present study, amino acid substitution in the QRDRs was also at the most frequently identified sites (2); codons 83 and 87 of gyrA, 447 of gyrB, 80 of parC, and 458 of parE. E. coli E81, E85, E94, E97, and E308 have parE mutations plus gyrA and parC; these isolates were more resistant than the others having gyrA and parC mutants in QRDR. The oqxB and gnrS genes were detected in one E. coli isolate having 2 QRDR mutations; this isolate exhibited resistance against 11 of the 14 antimicrobials. Recently, Wong et al. (19) also reported that Salmonella typhimurium isolates were positive for both oqx and aac(6')Ib-cr and had a single mutation in gyrA. The aac(6') Ib-cr was the most widely (85%) detected transmissible resistance gene and only two of the six PMQR genes were found in aac(6')Ib-cr-containing E. coli isolates. Overall, the E. coli isolates were very resistant against the selected antimicrobials, including PMQR positive isolates, whereas PMQR determinants conferred lowlevel quinolone resistance (20) . Reduced susceptibility by PMQR determinants is likely the most important factor that facilitates the selection of mutants with higher-level resistance (21) . When both qnr and aac(6')-Ib-cr genes are present in the same cell, resistance increases more than that conferred by qnr genes alone (15) .
The highly resistant isolates (E97, E100) carried a mix of different genetic determinants (QRDR mutations, aac(6')Ib-cr, and overexpressed acrB). However, there were more isolates that demonstrated derepression of soxS than those that carried PMQR genes. Oregan et al. (22) indicated that deletion of marA or soxS decreased ciprofloxacin MICs by 8-16-fold, and MDR isolates in which both marA and soxS were inactivated lost their MDR phenotype. The MIC changes are small and not clinically significant in the absence of the AcrAB-TolC system even if mutations in QRDR or PMQR genes are present (23) . However, it has also been demonstrated that alternative regulatory pathways exist that can result in overexpression of AcrAB-TolC independently of marA and soxS (16) . In the present study, a mix of resistance genes was found to be responsible for the high level of resistance in E. coli, but the role of the genes could not be estimated individually. This study is the first study to investigate MDR at the molecular level and to identify oqxB and aac(6')Ib-cr in E. coli isolates of animal origin in Turkey. The 20 distinct E. coli isolates, all with extensive antibiotic resistance, showed that accumulation of resistance genes in a reservoir creates a high risk for public health from direct contact with animals or consumption of their products.
